News Releases

June 16, 2014

RTI-HS staff led and presented 27 posters, several workshops, a sponsored educational symposium, and other sessions at the International Society for Pharmacoeconomics and Outcomes Research Annual Meeting in Montreal, Quebec, Canada, May 31-June 4, 2014. To access our full list of posters and...

May 20, 2014

A new book provides a definitive drug safety resource for pharmaceutical researchers and students. The book brings together 136 experts from around the world who represent all aspects of pharmacovigilance.

March 24, 2014

As long as statins, a class of cholesterol-lowering drugs, remain inexpensive and don’t affect the patient’s quality of life, it is better to simply prescribe the drugs before ordering a heart scan, finds a new study by researchers at University of California at San Francisco; RTI Health...

December 17, 2013

The Scottish Medicines Consortium (SMC) has recommended eltrombopag, for the treatment of thrombocytopenia in patients with hepatitis C virus. See Scottishmedicines.org.uk for additional details.

November 14, 2013

Susana Perez-Gutthann, global head of epidemiology at RTI Health Solutions, has been re-elected by her peers as one of the six research center members of the steering committee of the European...

November 12, 2013

Susana Perez-Gutthann, Vice President, and Global Head of Epidemiology will participate in a webinar entitled Practical Aspects and Examples of Using Large Datasets for Investigating Product Safety and Effectiveness in the US and EU for the DIA Global Forum for Therapeutic Innovation...

September 12, 2013

Researchers from RTI Health Solutions' (RTI-HS) Health Preference Assessment group will speak at an FDA-sponsored public workshop titled "...

July 11, 2013

Elizabeth Andrews, vice president of Pharmacoepidemiology and Risk Management, has been appointed to serve as the Academia/Research Institute representative on the Reagan-Udall...

May 22, 2013

Josephine Mauskopf, Ph.D., vice president of Health Economics at RTI Health Solutions, a business unit of RTI International, received the 2013 Avedis Donabedian Outcomes Research Lifetime Achievement Award...

April 15, 2013

A three-year European project SAFEGUARD, funded by the European Commission, aims to assess and further quantify and understand the effects of all existing blood glucose lowering agents in humans by means of the analysis of anonymised and aggregated data from more than 1.7 million diabetes...

March 7, 2013

Renowned pharmacoepidemiologist Ken Rothman, Distinguished Fellow, Vice President of Epidemiology Research, will join over 20 other leading experts to discuss applications of epidemiologic methods to social and health research.

February 10, 2013

Josephine Mauskopf, VP, Health Economics and Kati Copley-Merriman, VP, Outcomes co-authored a new study published in the Journal of ClinicoEconomics and Outcomes Research -...

February 7, 2013

Josephine Mauskopf, VP, Health Economics co-authored a new study published in the International Journal of Technology Assessment in Health Care - Relationship between financial...

November 12, 2012

RTI Health Solutions (RTI-HS) is implementing a 15-year surveillance study in the US to evaluate a potential association between use of Forteo (teriparatide), a medication used for osteoporosis, and development of osteosarcoma in adults. The safety study, which was initiated in 2003, is a...

November 12, 2012

Research scientists from RTI Health Solutions (RTI-HS) participated in an FDA workshop to discuss REMS assessments methods.

October 23, 2012

The three-year European project SAFEGUARD, funded by the European Commission, aims to assess and further quantify and understand the effects of all existing oral blood glucose lowering agents in humans by means of the analysis of anonymised and aggregated data from more than 1.7 million diabetes...

May 22, 2012

Dr. Elizabeth Andrews, Vice President, Pharmacoepidemiology and Risk Management, was selected by the UNC-CH Student Chapter of the International Society for Pharmacoepidemiology, The UNC Center of Excellence in Pharmacoepidemiology and Public Health, and the UNC Department of Epidemiology as the...

May 22, 2012

Dr. Alicia Gilsenan, Senior Director, Epidemiology, will serve as a panelist on an FDA workshop to discuss REMS assessments. The public workshop titled "Risk Evaluation and Mitigation Strategy Assessments: Social Science Methodologies to Assess Goals Related to Knowledge" is designed to share...

May 20, 2012

The Foundation for the National Institutes of Health (FNIH) announces the appointment of Elizabeth Andrews, Vice President, Pharmacoepidemiology and Risk Management at RTI Health Solutions to the Executive Board of the Observational Medical Outcomes Partnership (OMOP).

March 29, 2012

The London School of Hygiene and Tropical Medicine (LSHTM), a leading medical institution in Europe for research and postgraduate education will offer the course "Practical Pharmacoepidemiology" September 17-20, 2012.

The course is designed for postgraduate students with a basic grounding...

January 19, 2012

Alejandro Arana, MD, a pharmacoepidemiologist with over 15 years of experience, joined RTI Health Solutions (RTI-HS) as a Director of Epidemiology. He will be based in our Barcelona, Spain office.

October 4, 2011

Susana Perez-Gutthann, RTI Health Solutions Vice President and Global Head of Epidemiology will speak at the 2nd Joint DIA/EMA ENCePP to be held at the...

October 4, 2011

Susana Perez-Gutthann, RTI Health Solutions Vice President and Global Head of Epidemiology, will be a speaker at the Swedish Society for Pharmacoepidemiology 20th anniversary celebration event to be held on Wednesday October 19 at the Nobel Forum, Karolinska Institutet in Stockholm, Sweden.

Pages